Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S announced an update on its share repurchase program. The program, initiated on May 6, 2026, is part of an overall plan to repurchase up to DKK 15 billion worth of shares over a 12-month period starting February 4, 2026. As of September 25, 2026, the company had repurchased 35,379,179 B shares at an average price of DKK 280.95, totaling DKK 9,939,842,031. The update details transactions made from September 21 to September 25, 2026, during which 1,155,000 B shares were repurchased for a total value of DKK 291,368,000. Following these transactions, Novo Nordisk holds 49,419,876 B shares as treasury shares, representing 1.1% of the total share capital. The company expects to continue repurchasing shares up to the DKK 15 billion limit.